Novel combinations with programmed cell death 1 inhibitor for incurable recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC): is cabozantinib a front runner? - Bhateja, Priyanka; Bonomi, Marcelo; Verschraegen, Claire (Translational Cancer Research, 2025)